The CGT frontier: what to prioritise in the transition from clinical to commercial
The cell and gene therapy (CGT) industry is growing fast but manufacturing is not straightforward.
MasterControl
ICH E6(R3) in effect: transforming quality management for cell and gene therapy trials
How to build flexibility into your CGT manufacturing process while maintaining regulatory compliance
How to solve the big challenges of cell and gene therapy manufacturing
Navigating the AI regulatory maze: Why 91% of life sciences professionals feel lost
